4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000029
Chief Medical Officer sold 55,771 shares at an average $15.76 ($879,008)
- Chief Medical Officer acquired 1,606 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-04-01 | Option exercise 10b5-1 | +1,606 | $1.08 | $1,734 | 172,475 | D |
| Rodman David Malcom Chief Medical Officer | 2025-04-01 | Sale 10b5-1 | −30,574 | $15.00 | $458,543 | 141,901 | D |
| Rodman David Malcom Chief Medical Officer | 2025-04-01 | Sale 10b5-1 | −2,791 | $16.02 | $44,717 | 139,110 | D |
| Rodman David Malcom Chief Medical Officer | 2025-04-01 | Sale 10b5-1 | −22,406 | $16.77 | $375,749 | 116,704 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-04-01 | Option exercise · Stock Option 10b5-1 | −1,606 | 114,274 | D | ||
| Open-market sales · 55,771 sh · avg $15.76 · $879,008 | |||||||
Loading xslF345X05/wk-form4_1743716211.xml…